BioSpace News Archive

ENDRA Life Sciences to Present at the H.C. Wainwright Global Investment Conference.

IVERIC bio, Inc. announced that Pravin U. Dugel, M.D., President, will present a corporate overview at the H.C. Wainwright Global Investment Conference, being held from May 23-26, 2022.

PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics.

Richard A. Kayne, who together with his affiliates beneficially owns approximately 4.8% of the outstanding shares of common stock of Athira Pharma, Inc., issued the following letter to Athira shareholders.

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), today will present its first research data on the development of a novel universal CAR T-cell with immune-evasive properties using TALEN®-gene editing, at the American Society of Cell and Gene Therapy Annual Meeting (ASGCT) being held on May 16-19, 2022.

RootPath announced that a poster presentation highlighting its lead therapeutic candidates, a series of fully personalized T cell therapies, at the American Society of Gene & Cell Therapy 25th Annual Meeting taking place May 16-19, 2022 in Washington, D.C.

Vaccinex Reports First Quarter 2022 Results and Provides Corporate Update.

Magenta Therapeutics Reports First Quarter Financial Results, Early Clinical Observations from MGTA-117 Clinical Trial and Other Program Highlights.

The PPD clinical research business of Thermo Fisher Scientific has been recognized for excellence in the 2022 CRO Leadership Awards.

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that it will host a virtual R&D Day for investors and analysts on Friday, June 10, 2022 at 10:00 am ET.